693 related articles for article (PubMed ID: 31997613)
21. Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis.
Sukasem C; Sririttha S; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Suvannang N; Rungrotmongkol T; Saokaew S; Aekplakorn W; Puangpetch A
Pharmacogenomics J; 2021 Dec; 21(6):682-690. PubMed ID: 34175889
[TBL] [Abstract][Full Text] [Related]
22. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.
Cheung YK; Cheng SH; Chan EJ; Lo SV; Ng MH; Kwan P
Epilepsia; 2013 Jul; 54(7):1307-14. PubMed ID: 23692434
[TBL] [Abstract][Full Text] [Related]
23. Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population.
Ihtisham K; Ramanujam B; Srivastava S; Mehra NK; Kaur G; Khanna N; Jain S; Kumar S; Kaul B; Samudrala R; Tripathi M
Seizure; 2019 Mar; 66():99-103. PubMed ID: 30826555
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database.
Kim HK; Jang KS; Kim DW
Epilepsy Behav; 2024 May; 154():109784. PubMed ID: 38636107
[TBL] [Abstract][Full Text] [Related]
25. [Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia].
Gamba C; Schroeder J; Citterio A; Cazzaniga S; Rivolta AL; Vighi G;
Recenti Prog Med; 2014 Oct; 105(10):379-84. PubMed ID: 25282350
[TBL] [Abstract][Full Text] [Related]
26. Lamotrigine-induced severe cutaneous adverse reactions.
Schlienger RG; Shapiro LE; Shear NH
Epilepsia; 1998; 39 Suppl 7():S22-6. PubMed ID: 9798758
[TBL] [Abstract][Full Text] [Related]
27. Use and safety profile of antiepileptic drugs in Italy.
Iorio ML; Moretti U; Colcera S; Magro L; Meneghelli I; Motola D; Rivolta AL; Salvo F; Velo GP
Eur J Clin Pharmacol; 2007 Apr; 63(4):409-15. PubMed ID: 17347806
[TBL] [Abstract][Full Text] [Related]
28. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
29. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs.
Pereira de Silva N; Piquioni P; Kochen S; Saidon P
Eur J Clin Pharmacol; 2011 May; 67(5):463-70. PubMed ID: 21359537
[TBL] [Abstract][Full Text] [Related]
31. Common allergies do not influence the prevalence of cutaneous hypersensitivity reactions to antiepileptic drugs.
Bosak M; Porębski G; Słowik A; Turaj W
Epilepsy Res; 2017 Sep; 135():9-13. PubMed ID: 28552676
[TBL] [Abstract][Full Text] [Related]
32. The Frequency and Clinical Features of Hypersensitivity Reactions to Antiepileptic Drugs in Children: A Prospective Study.
Guvenir H; Dibek Misirlioglu E; Civelek E; Toyran M; Buyuktiryaki B; Ginis T; Capanoglu M; Gurkas E; Guven A; Kocabas CN
J Allergy Clin Immunol Pract; 2018; 6(6):2043-2050. PubMed ID: 29501520
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and prognostic factors in severe cutaneous drug reactions.
Yang MS; Kang MG; Jung JW; Song WJ; Kang HR; Cho SH; Min KU
Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
[TBL] [Abstract][Full Text] [Related]
34. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
[TBL] [Abstract][Full Text] [Related]
35. A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
Kang DY; Yun J; Lee SY; Koh YI; Sim DW; Kim S; Nam YH; Park JW; Kim SH; Ye YM; Park HK; Kim MH; Jee YK; Jung JW; Yang MS; Kim SH; Lee JK; Kim CW; Hur GY; Kim MY; Park SJ; Kwon YE; Choi JH; Kim JH; Kim SH; La HO; Kang MG; Park CS; Lee SM; Jeong YY; Kim HK; Jin HJ; Jeong JW; Lee J; Lee YW; Lee SE; Kim MS; Kang HR;
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):929-936.e7. PubMed ID: 32961314
[TBL] [Abstract][Full Text] [Related]
36. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
[TBL] [Abstract][Full Text] [Related]
37. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
[TBL] [Abstract][Full Text] [Related]
38. Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
Australas J Dermatol; 2024 May; 65(3):243-253. PubMed ID: 38572842
[TBL] [Abstract][Full Text] [Related]
39. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.
Lin YT; Chang YC; Hui RC; Yang CH; Ho HC; Hung SI; Chung WH
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):356-64. PubMed ID: 22211830
[TBL] [Abstract][Full Text] [Related]
40. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions.
Chu MT; Wang CW; Chang WC; Chen CB; Chung WH; Hung SI
J Invest Dermatol; 2021 Jun; 141(6):1461-1472.e10. PubMed ID: 33340500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
